Susquehanna International Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-11,138
| Closed | -$139K | – | 10819 |
|
|
2016
Q4 | $139K | Sell |
11,138
-5,983
| -35% | -$72.1K | ﹤0.01% | 8899 |
|
|
2016
Q3 | $234K | Buy |
+17,121
| New | +$172K | ﹤0.01% | 7331 |
|
|
2016
Q2 | – | Sell |
-284,972
| Closed | -$2.14M | – | 9889 |
|
|
2016
Q1 | $1.82M | Sell |
284,972
-360,128
| -56% | -$2.02M | ﹤0.01% | 3966 |
|
|
2015
Q4 | $4.03M | Sell |
645,100
-71,302
| -10% | -$468K | ﹤0.01% | 2824 |
|
|
2015
Q3 | $4.18M | Buy |
716,402
+381,333
| +114% | +$2.94M | ﹤0.01% | 2941 |
|
|
2015
Q2 | $2.77M | Sell |
335,069
-153,587
| -31% | -$1.36M | ﹤0.01% | 4011 |
|
|
2015
Q1 | $4.03M | Sell |
488,656
-1,235,227
| -72% | -$9.13M | ﹤0.01% | 3059 |
|
|
2014
Q4 | $11.8M | Buy |
1,723,883
+236,134
| +16% | +$1.48M | ﹤0.01% | 1849 |
|
|
2014
Q3 | $8.03M | Sell |
1,487,749
-309,662
| -17% | -$1.81M | ﹤0.01% | 2360 |
|
|
2014
Q2 | $11.4M | Buy |
1,797,411
+415,931
| +30% | +$2.86M | ﹤0.01% | 1954 |
|
|
2014
Q1 | $11.1M | Sell |
1,381,480
-1,358,783
| -50% | -$10.6M | 0.01% | 1896 |
|
|
2013
Q4 | $18.7M | Buy |
2,740,263
+2,215,605
| +422% | +$12M | 0.01% | 1413 |
|
|
2013
Q3 | $9.65M | Buy |
524,658
+367,889
| +235% | +$7.14M | 0.01% | 1953 |
|
|
2013
Q2 | $2.74M | Buy |
+156,769
| New | +$2.78M | ﹤0.01% | 3409 |
|
Other funds holding ARIA
Susquehanna International Group's ARIA Position: Q1 2017 in Review
Susquehanna International Group sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 11,138 shares — an estimated $139K sold.
Susquehanna International Group first reported a position in ARIA in Q2 2013 and held it in 14 quarters. The position peaked at $18.7M in Q4 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.
- Susquehanna International Group reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
- Susquehanna International Group sold 11,138 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $139K.
- Susquehanna International Group first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 14 quarters.
- Susquehanna International Group's Ariad Pharmaceuticals Inc position peaked at $18.7M in Q4 2013.
- 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.
Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.